NVCR News - Candlesense

Novocure Announces Upcoming Investor Events

BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced today that management will participate in three upcoming investor events. 2025 Wells Fargo Healthcare Conference, September 4, ...

Investor events

14 days ago

Novocure Submits Premarket Approval Application to FDA for Tumor Treating Fields Therapy in Locally Advanced Pancreatic Cancer

BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) today announced it submitted a premarket approval (PMA) application to the U.S. Food and Drug Administration (FDA) for Tumor Treating Fie...

What is the market size and competitive landscape for TTFields therapy in pancreatic cancer versus existing treatments? How might the PMA submission affect NVCR's short‑term stock volatility and trading volume? What is the expected timeline for FDA decision and potential market launch?

Regulatory

22 days ago